Cargando…

Establishment and validation of a predictive model of recurrence in primary hepatocellular carcinoma after resection

BACKGROUND: In recent years, nomogram prediction models have been widely used to evaluate the prognosis of various diseases. However, studies in primary hepatocellular carcinoma (HCC) are limited. This study sought to explore the risk factors of recurrence of patients with primary HCC after surgical...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Yang, Han, Huimin, Cao, Wei, Fu, Hongxing, Liu, Yang, Yan, Li, Qin, Tingting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10007949/
https://www.ncbi.nlm.nih.gov/pubmed/36915435
http://dx.doi.org/10.21037/jgo-22-1303
_version_ 1784905645782204416
author Xu, Yang
Han, Huimin
Cao, Wei
Fu, Hongxing
Liu, Yang
Yan, Li
Qin, Tingting
author_facet Xu, Yang
Han, Huimin
Cao, Wei
Fu, Hongxing
Liu, Yang
Yan, Li
Qin, Tingting
author_sort Xu, Yang
collection PubMed
description BACKGROUND: In recent years, nomogram prediction models have been widely used to evaluate the prognosis of various diseases. However, studies in primary hepatocellular carcinoma (HCC) are limited. This study sought to explore the risk factors of recurrence of patients with primary HCC after surgical resection and establish a nomogram prediction model. METHODS: The data of 424 patients with primary HCC who had been admitted to the Wuhan Third Hospital were retrospectively collected. The patients were followed-up for 5 years after surgery. The patients were divided into the recurrence group (n=189) and control group (n=235) according to whether the cancer recurred after surgery. The differences in the clinical characteristics between the two groups were analyzed. The risk factors of recurrence after surgical resection of primary HCC were also analyzed, and a prediction model was then established using R4.0.3 statistical software. RESULTS: There were significant statistical differences between the two groups in terms of the tumor size, systemic immune-inflammation (SII) index, the number of lesions, tumor differentiation degree, ascites, vascular invasion, and portal vein tumor thrombus (P<0.05). The multivariate regression analysis showed that multiple foci, poorly differentiated tumors, ascites, vascular invasion, and portal vein tumor thrombus were risk factors for the recurrence of primary HCC in patients after surgical resection (P<0.05). The data set was randomly divided into a training set and verification set. The sample size of the training set was 297, and the sample size of the verification set was 127. The area under the receiver operating characteristic (ROC) curve of the training set was 0.866 [95% confidence interval (CI): 0.824–0.907], and the area under the ROC curve of the validation set was 0.812 (95% CI: 0.734–0.890). The Hosmer-Lemeshow Goodness-of-Fit Test was used to test the model with the validation set (χ(2)=11.243, P=0.188), which indicated that the model had high value in predicting the recurrence of primary HCC after surgical resection. CONCLUSIONS: This model had high value in predicting the recurrence of primary HCC in patients after surgical resection. This model could assist clinicians to assess the prognosis of patients. Intensive treatment for high-risk patients might improve the prognosis of patients.
format Online
Article
Text
id pubmed-10007949
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-100079492023-03-12 Establishment and validation of a predictive model of recurrence in primary hepatocellular carcinoma after resection Xu, Yang Han, Huimin Cao, Wei Fu, Hongxing Liu, Yang Yan, Li Qin, Tingting J Gastrointest Oncol Original Article BACKGROUND: In recent years, nomogram prediction models have been widely used to evaluate the prognosis of various diseases. However, studies in primary hepatocellular carcinoma (HCC) are limited. This study sought to explore the risk factors of recurrence of patients with primary HCC after surgical resection and establish a nomogram prediction model. METHODS: The data of 424 patients with primary HCC who had been admitted to the Wuhan Third Hospital were retrospectively collected. The patients were followed-up for 5 years after surgery. The patients were divided into the recurrence group (n=189) and control group (n=235) according to whether the cancer recurred after surgery. The differences in the clinical characteristics between the two groups were analyzed. The risk factors of recurrence after surgical resection of primary HCC were also analyzed, and a prediction model was then established using R4.0.3 statistical software. RESULTS: There were significant statistical differences between the two groups in terms of the tumor size, systemic immune-inflammation (SII) index, the number of lesions, tumor differentiation degree, ascites, vascular invasion, and portal vein tumor thrombus (P<0.05). The multivariate regression analysis showed that multiple foci, poorly differentiated tumors, ascites, vascular invasion, and portal vein tumor thrombus were risk factors for the recurrence of primary HCC in patients after surgical resection (P<0.05). The data set was randomly divided into a training set and verification set. The sample size of the training set was 297, and the sample size of the verification set was 127. The area under the receiver operating characteristic (ROC) curve of the training set was 0.866 [95% confidence interval (CI): 0.824–0.907], and the area under the ROC curve of the validation set was 0.812 (95% CI: 0.734–0.890). The Hosmer-Lemeshow Goodness-of-Fit Test was used to test the model with the validation set (χ(2)=11.243, P=0.188), which indicated that the model had high value in predicting the recurrence of primary HCC after surgical resection. CONCLUSIONS: This model had high value in predicting the recurrence of primary HCC in patients after surgical resection. This model could assist clinicians to assess the prognosis of patients. Intensive treatment for high-risk patients might improve the prognosis of patients. AME Publishing Company 2023-02-15 2023-02-28 /pmc/articles/PMC10007949/ /pubmed/36915435 http://dx.doi.org/10.21037/jgo-22-1303 Text en 2023 Journal of Gastrointestinal Oncology. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Xu, Yang
Han, Huimin
Cao, Wei
Fu, Hongxing
Liu, Yang
Yan, Li
Qin, Tingting
Establishment and validation of a predictive model of recurrence in primary hepatocellular carcinoma after resection
title Establishment and validation of a predictive model of recurrence in primary hepatocellular carcinoma after resection
title_full Establishment and validation of a predictive model of recurrence in primary hepatocellular carcinoma after resection
title_fullStr Establishment and validation of a predictive model of recurrence in primary hepatocellular carcinoma after resection
title_full_unstemmed Establishment and validation of a predictive model of recurrence in primary hepatocellular carcinoma after resection
title_short Establishment and validation of a predictive model of recurrence in primary hepatocellular carcinoma after resection
title_sort establishment and validation of a predictive model of recurrence in primary hepatocellular carcinoma after resection
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10007949/
https://www.ncbi.nlm.nih.gov/pubmed/36915435
http://dx.doi.org/10.21037/jgo-22-1303
work_keys_str_mv AT xuyang establishmentandvalidationofapredictivemodelofrecurrenceinprimaryhepatocellularcarcinomaafterresection
AT hanhuimin establishmentandvalidationofapredictivemodelofrecurrenceinprimaryhepatocellularcarcinomaafterresection
AT caowei establishmentandvalidationofapredictivemodelofrecurrenceinprimaryhepatocellularcarcinomaafterresection
AT fuhongxing establishmentandvalidationofapredictivemodelofrecurrenceinprimaryhepatocellularcarcinomaafterresection
AT liuyang establishmentandvalidationofapredictivemodelofrecurrenceinprimaryhepatocellularcarcinomaafterresection
AT yanli establishmentandvalidationofapredictivemodelofrecurrenceinprimaryhepatocellularcarcinomaafterresection
AT qintingting establishmentandvalidationofapredictivemodelofrecurrenceinprimaryhepatocellularcarcinomaafterresection